These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

911 related articles for article (PubMed ID: 6207009)

  • 1. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
    Elks ML; Manganiello VC
    Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for soluble cAMP phosphodiesterases in differentiation of 3T3-L1 adipocytes.
    Elks ML; Manganiello VC
    J Cell Physiol; 1985 Aug; 124(2):191-8. PubMed ID: 2413050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dexamethasone on adenosine 3',5'-monophosphate content and phosphodiesterase activities in 3T3-L1 adipocytes.
    Elks ML; Manganiello VC; Vaughan M
    Endocrinology; 1984 Oct; 115(4):1350-6. PubMed ID: 6207010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antilipolytic action of insulin: role of cAMP phosphodiesterase activation.
    Elks ML; Manganiello VC
    Endocrinology; 1985 May; 116(5):2119-21. PubMed ID: 2985373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in cyclic AMP phosphodiesterase activities during differentiation of 3T3-L1 cells.
    Manganiello VC; Reed BC; Lieberman FS; Moss J; Lane MD; Vaughan M
    J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(2):143-54. PubMed ID: 6196386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of thyroid hormone on regulation of lipolysis and adenosine 3',5'-monophosphate metabolism in 3T3-L1 adipocytes.
    Elks ML; Manganiello VC
    Endocrinology; 1985 Sep; 117(3):947-53. PubMed ID: 2410243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis.
    Torphy TJ; Zhou HL; Burman M; Huang LB
    Mol Pharmacol; 1991 Mar; 39(3):376-84. PubMed ID: 1848659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissimilar cyclic nucleotide phosphodiesterase activities in subcellular fractions from normal and SV40-transformed WI-38 fibroblasts.
    Nemecek GM; Butcher RW
    J Cyclic Nucleotide Res; 1979 Dec; 5(6):449-61. PubMed ID: 94064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of two phosphodiesterase inhibitors on fat cell metabolism.
    Shechter Y
    Endocrinology; 1984 Nov; 115(5):1787-91. PubMed ID: 6208014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of intracellular calcium ([Ca2+]i) inhibition of lipolysis in human adipocytes.
    Xue B; Greenberg AG; Kraemer FB; Zemel MB
    FASEB J; 2001 Nov; 15(13):2527-9. PubMed ID: 11641262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex effects of inhibitors on cyclic GMP-stimulated cyclic nucleotide phosphodiesterase.
    Yamamoto T; Yamamoto S; Osborne JC; Manganiello VC; Vaughan M; Hidaka H
    J Biol Chem; 1983 Dec; 258(23):14173-7. PubMed ID: 6196360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of N6-(L-2-phenylisopropyl)adenosine and insulin on cAMP metabolism in 3T3-L1 adipocytes.
    Elks ML; Jackson M; Manganiello VC; Vaughan M
    Am J Physiol; 1987 Mar; 252(3 Pt 1):C342-8. PubMed ID: 3030132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone-sensitive particulate cAMP phosphodiesterase activity in 3T3-L1 adipocytes. Regulation of responsiveness by dexamethasone.
    Elks ML; Manganiello VC; Vaughan M
    J Biol Chem; 1983 Jul; 258(14):8582-7. PubMed ID: 6190811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine attenuates cAMP-induced lipolysis via reducing the inhibition of phosphodiesterase in 3T3-L1 adipocytes.
    Zhou L; Wang X; Yang Y; Wu L; Li F; Zhang R; Yuan G; Wang N; Chen M; Ning G
    Biochim Biophys Acta; 2011 Apr; 1812(4):527-35. PubMed ID: 20969954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P; Lugnier C; Demesy-Waeldele F; Stoclet JC
    Biochem Pharmacol; 1987 Nov; 36(22):3965-72. PubMed ID: 2825708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of different phosphodiesterase inhibitors on the antilipolytic action of insulin in human adipocytes.
    Kather H; Scheurer A
    Horm Metab Res; 1987 Aug; 19(8):379-81. PubMed ID: 2822563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma membrane-bound cyclic AMP phosphodiesterase activity in 3T3-L1 adipocytes.
    Zhang X; Carey GB
    Comp Biochem Physiol B Biochem Mol Biol; 2004 Mar; 137(3):309-16. PubMed ID: 15050518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antilipolytic effect of insulin does not require adenylate cyclase or phosphodiesterase action.
    Gabbay RA; Lardy HA
    FEBS Lett; 1985 Jan; 179(1):7-11. PubMed ID: 2981181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of insulin-sensitive phosphodiesterase in insulin action.
    Makino H; Suzuki T; Kajinuma H; Yamazaki M; Ito H; Yoshida S
    Adv Second Messenger Phosphoprotein Res; 1992; 25():185-99. PubMed ID: 1372810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a liver low Michaelis-Menten constant 3',5'-cyclic adenosine monophosphate phosphodiesterase activity sensitive to thyroid status.
    Benelli C; Geoffroy V; Fouque F; Lopez S; Desbuquois B
    Endocrinology; 1991 May; 128(5):2376-86. PubMed ID: 1850351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.